Picture of Destiny Pharma logo

DEST Destiny Pharma News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

REG - AIM - AIM Notice - 29/03/2022

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220329:nRSc2960Ga&default-theme=true

RNS Number : 2960G  AIM  29 March 2022

NOTICE

 

29/03/2022 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 ABCAM PLC                                            BLOCK ADMISSION
 850,000    ORDINARY SHARES OF 0.2P EACH, FULLY PAID  (B677469)(GB00B6774699)
 3,500,000  ORDINARY SHARES OF 0.2P EACH, FULLY PAID  (B677469)(GB00B6774699)

 

 AURA ENERGY LIMITED
 4,237,476  ORDINARY SHARES OF NO PAR VALUE FULLY PAID (DI)  (BD1RHP4)(AU000000AEE7)

 

 BEGBIES TRAYNOR GROUP PLC
 24,225  ORDINARY SHARES OF 5P EACH, FULLY PAID  (B0305S9)(GB00B0305S97)

 

 BLUEJAY MINING PLC
 76,857,134  ORDINARY SHARES OF 0.01P EACH FULLY PAID  (BFD3VF2)(GB00BFD3VF20)

 

 CORCEL PLC
 24,333,332  ORDINARY SHARES OF 0.01P EACH, FULLY PAID  (BKM6986)(GB00BKM69866)

 

 DESTINY PHARMA PLC
 12,000,000  ORDINARY SHARES OF GBP0.01 EACH, FULLY PAID  (BDHSP57)(GB00BDHSP575)
 909,007     ORDINARY SHARES OF GBP0.01 EACH, FULLY PAID  (BDHSP57)(GB00BDHSP575)

 

 FRANCHISE BRANDS PLC
 1,611,234  ORDINARY SHARES OF 0.5P EACH, FULLY PAID  (BD6P7Y2)(GB00BD6P7Y24)

 

 IDOX PLC
 50,000  ORDINARY SHARES OF 1P EACH, FULLY PAID  (0299819)(GB0002998192)

 

 PETROTAL CORPORATION
 267,500  COMMON SHARES OF NO PAR VALUE, FULLY PAID (DI)  (BH3FL85)(CA71677J1012)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOBLGDXDBDDGDI

Recent news on Destiny Pharma

See all news